Basal Cell Carcinoma - cancer
Aging, Environment, & DiseaseTools & Technology

A New and Targetable Epigenetic Biomarker for the Most Common Cancer

Basal cell carcinoma (BCC) is the most common cancer in people of Caucasian descent. BCC affects 2-3.5 million Americans yearly, and in some countries such as Denmark, BCCs outnumber all other cancers combined. Most BCCs can be successfully treated with surgery, particularly using Mohs micrographic surgical techniques, but some BCC …

Histone ModificationsUncategorized

EZH2: A New Biomarker and Epigenetic Target for Retinoblastoma

Retinoblastoma (RB) is the most common primary eye cancer in children, the third most common cancer in infants younger than 1 year and accounts for 12% of all infantile cancers per year. RB can be blinding and lethal, and is caused by mutations in the tumor suppressor gene RB1. However, current …